About Orbicular Pharmaceutical Technologies Private Limited
Data last updated: 06 February 2026
Orbicular Pharmaceutical Technologies Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 13 August 2008, the company has been in operation for over 18 years.
Registered with ROC Hyderabad under CIN U24233TG2008PTC060606.
Capital: an authorised share capital of ₹12 Cr and a paid-up capital of ₹11.18 Cr. It is led by directors including Mohan Sivaraman Mailtur and Bhavesh Vallabhbhai Patel.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: P.No 53 Aleap Industrial Estate Gajularamaram Behind Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2025, the company reported a revenue of ₹272.04 Cr, a growth of 41% compared to the previous year.
The company has a workforce of approximately 253 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Orbicular Pharmaceutical Technologies. As per MCA filings, the company has open charges of ₹461.75 Cr and satisfied charges of ₹15.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orbicular.co.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressP.No 53 Aleap Industrial Estate Gajularamaram Behind Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited has one previous CIN (Corporate Identification Number): U24233AP2008PTC060606. The current CIN is U24233TG2008PTC060606, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2008PTC060606 | Current |
| U24233AP2008PTC060606 | Previous |
Associated Brands with Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited operates one associated brand: Orbicular Pharmaceutical Technologies. These brands represent Orbicular Pharmaceutical Technologies Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of niche generic and specialty pharmaceutical products | orbicular.co.in |
Competitors & Alternatives of Orbicular Pharmaceutical Technologies Private Limited
Brands and companies operating in the same space as Orbicular Pharmaceutical Technologies Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Orbicular Pharmaceutical Technologies Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited is audited by MN Reddy & Co for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MN Reddy & Co | Locked | Locked | Locked |
Complete auditor history for Orbicular Pharmaceutical Technologies Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited is currently managed by 6 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohan Sivaraman Mailtur | Managing Director | 06 Aug 2010 | 16 Years 0 Months | Current |
|
Bhavesh Vallabhbhai Patel
Also directs:
Invitron Advanced Analytics Private Limited
|
Director | 01 Apr 2022 | 4 Years 4 Months | Current |
|
Visalakshi Chandramouli
Also directs:
Sakar Healthcare Limited, Brinton Pharmaceuticals Limited, Linux Laboratories Private Limited and 4 more
|
Nominee Director | 31 May 2024 | 2 Years 2 Months | Current |
| Meena Mohan | Director | 13 Aug 2008 | 18 Years 0 Months | Current |
| Hiren Dasharathbhai Patel | Director | 24 Aug 2012 | 13 Years 11 Months | Current |
| Rahul Gawande Sudhakar | Director | 01 Jul 2019 | 7 Years 1 Months | Current |
Financials of Orbicular Pharmaceutical Technologies Private Limited FY 2025 filings available
Orbicular Pharmaceutical Technologies Private Limited reported revenue of ₹272.04 Cr (up 41.00% YoY) for FY 2025.
Ten-year financial statements for Orbicular Pharmaceutical Technologies Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Orbicular Pharmaceutical Technologies Private Limited
Shareholding and ownership data for Orbicular Pharmaceutical Technologies Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Orbicular Pharmaceutical Technologies Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Invitron Advanced Analytics Private Limited | U73100TG2013PTC087372 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Orbicular Pharmaceutical Technologies Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2025 | Hdfc Bank Limited | ₹40 Cr | Open |
| 24 Nov 2025 | Hdfc Bank Limited | ₹60 Cr | Open |
| 30 Oct 2025 | Others | ₹8 Cr | Open |
| 28 Jun 2025 | Others | ₹4.5 Cr | Open |
| 28 Jun 2025 | Others | ₹23 Cr | Open |
Total charge records: 19 View all charges
Employees and EPFO Compliance at Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited has a workforce of 253 employees as of Dec 11, 2025.
Employee and EPFO history for Orbicular Pharmaceutical Technologies Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Orbicular Pharmaceutical Technologies Private Limited
GST registrations and filing compliance for Orbicular Pharmaceutical Technologies Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Orbicular Pharmaceutical Technologies Private Limited
Credit ratings, litigation, and regulatory alerts for Orbicular Pharmaceutical Technologies Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Orbicular Pharmaceutical Technologies Private Limited
MSME payment history for Orbicular Pharmaceutical Technologies Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Orbicular Pharmaceutical Technologies Private Limited
Corporate group structure for Orbicular Pharmaceutical Technologies Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Orbicular Pharmaceutical Technologies Private Limited
MCA filings and documents for Orbicular Pharmaceutical Technologies Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Orbicular Pharmaceutical Technologies Private Limited
Recent News on Orbicular Pharmaceutical Technologies Private Limited
Frequently Asked Questions about Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 13 August 2008 (18+ years old) and is registered under CIN U24233TG2008PTC060606. The company has 253 employees.
Orbicular Pharmaceutical Technologies Private Limited reported revenue of ₹272.04 Cr for FY 2025 (up 41.00% YoY).
The current directors of Orbicular Pharmaceutical Technologies Private Limited are:
- Mohan Sivaraman Mailtur - Managing Director
- Bhavesh Vallabhbhai Patel - Director
- Visalakshi Chandramouli - Nominee Director
- Meena Mohan - Director
- Hiren Dasharathbhai Patel - Director
- Rahul Gawande Sudhakar - Director
The primary industry of Orbicular Pharmaceutical Technologies Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Orbicular Pharmaceutical Technologies Private Limited can be reached at the registered office: P.No 53 Aleap Industrial Estate Gajularamaram Behind Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090, or through the website orbicular.co.in.
The authorised capital is ₹12 Cr, and the paid-up capital is ₹11.18 Cr.